Pharmaceutical companies are generally blamed for America’s high prescription drug prices, but they aren’t the first place to look.
Cigna to buy Express Scripts in $67 billion deal
Supply chain experts are skeptical the $67 billion Cigna Corp.-Express Scripts deal will do much to transform the healthcare industry, let alone deliver any significant savings to customers.
Cigna’s plan to buy Express Scripts is no boon to drug purchasers
Cigna unveiled plans this week to acquire pharmacy benefits manager Express Scripts, accelerating the trend toward healthcare supply-chain consolidation.
Memo to EHR vendors from an EHR CTO: It’s time for true drug price transparency
EHR vendors face a tough challenge in deciding which new features to develop and integrate for their next release and which ones to leave on the cutting room floor.
HIStalk Interviews Tom Borzilleri, CEO, InteliSys Health
Tell me about yourself and the company: I spent many years in the finance business. My first dive into the healthcare space was back in the late 1990s, having founded and operated the second-largest patient finance company in the country. As I progressed on through the years and had a successful exit of that company, I then moved into the PBM space in the mid-2000s.
Readers Write: It’s Time for Drug Price Transparency
EHR vendors face a tough challenge in deciding which new features to develop and integrate for their next release and which ones to leave on the cutting room floor. The benefits of each potential enhancement must be weighed against the costs, usually measured in programming time. Moreover, features required for Meaningful Use and MIPS must be included, making the triage even more difficult.
Pricing Front and Center
Pharmaceutical pricing is a complex — and often controversial — issue impacting all stakeholders in healthcare.
The CVS Health-Aetna deal: Are patients winners or losers? How will Amazon and Google react? 8 key questions answered
CVS Health announced plans to acquire Aetna earlier this week for $69 billion, and leaders across healthcare are examining what the deal could mean for the industry going forward.
Does Amazon Have What It Takes to Transform the Pharma Industry?
From basics like toilet paper to luxuries such as flatscreen TVs, Amazon can deliver just about anything to a doorstep these days—so, what about prescription drugs? That’s the question the company seems to be currently asking itself and is expected to announce its answer soon.
Jury is Out on Possible Effects of CVS/Aetna Merger-Could result in fewer choices for Aetna enrollees, observers say
If the proposed $69-billion purchase of health insurer Aetna by CVS — a pharmacy chain that is also a pharmacy benefit manager (PBM) — is approved, it may be good news for the companies involved, but its potential effects on patients and providers are not so clear, experts say.